Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial to Assess the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regimen for Calculating Warfarin Maintenance Dose

NCT00700895 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT00700895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00700895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial to Assess the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regimen for Calculating Warfarin Maintenance Dose
Lead sponsor
National University Hospital, Singapore
Phase
Phase 3
Overall status
Unknown status
Start date
August 31, 2006
Completion date
August 31, 2017
Enrollment
320 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

indications for warfarin therapy